Bilan français des effets indésirables du vaccin Prévenar 13®

Post-licensure safety surveillance for Prevenar 13® in France. MS. Agier, S. Marchand, N.Paret, S.Gautier, A.-P. Jonville-Béra Arch Pediatr 2017 feb 24 pii: S0929-693X(17)30044-1

10.1016/j.arcped.2017.01.018

https://www.ncbi.nlm.nih.gov/pubmed/28242152